These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 19465161)
41. DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians. Shaheen IA; Abukhalil RE; Ali DK; Afifi RA Blood Coagul Fibrinolysis; 2012 Oct; 23(7):636-9. PubMed ID: 22885766 [TBL] [Abstract][Full Text] [Related]
42. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315 [TBL] [Abstract][Full Text] [Related]
43. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366 [TBL] [Abstract][Full Text] [Related]
44. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation. Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474 [TBL] [Abstract][Full Text] [Related]
45. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population. Bayram S Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463 [TBL] [Abstract][Full Text] [Related]
46. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Zhu Y; Spitz MR; Lei L; Mills GB; Wu X Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799 [TBL] [Abstract][Full Text] [Related]
47. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Chen GG; Ho RL; Wong J; Lee KF; Lai PB Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605 [TBL] [Abstract][Full Text] [Related]
48. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study. Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700 [TBL] [Abstract][Full Text] [Related]
49. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men]. Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206 [TBL] [Abstract][Full Text] [Related]
50. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma. Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572 [TBL] [Abstract][Full Text] [Related]
51. Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma. Hsu LM; Huang YS; Yang SY; Chang FY; Lee SD Anticancer Res; 2006; 26(5B):3787-91. PubMed ID: 17094402 [TBL] [Abstract][Full Text] [Related]
52. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604 [TBL] [Abstract][Full Text] [Related]
53. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome. Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874 [TBL] [Abstract][Full Text] [Related]
54. Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma. Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B J Viral Hepat; 2010 Sep; 17(9):668-74. PubMed ID: 20002563 [TBL] [Abstract][Full Text] [Related]
55. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505 [TBL] [Abstract][Full Text] [Related]
56. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549 [TBL] [Abstract][Full Text] [Related]
57. MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population. Ezzikouri S; El Feydi AE; Afifi R; El Kihal L; Benazzouz M; Hassar M; Marchio A; Pineau P; Benjelloun S Cancer Detect Prev; 2009; 32(5-6):380-5. PubMed ID: 19233569 [TBL] [Abstract][Full Text] [Related]
58. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077 [TBL] [Abstract][Full Text] [Related]
59. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055 [TBL] [Abstract][Full Text] [Related]
60. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]